R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 18,784 shares at $21.72 ($408K) on 2016-12-30, disclosed to the SEC on 2017-01-04.
Open-market purchase of $408k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 9,392 | $204K | 50.0% |
| 2 | $21.72 | 9,392 | $204K | 50.0% |
| Total | $21.72 avg | 18,784 | $408K | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |